Ionis grants Recordati ex-U.S. rights to zilganersen for Alexander disease while retaining U.S. commercialization and securing upfront and royalty payments.

TRNO boosts income visibility with early lease renewals and new industrial deals as rent growth and tenant retention stay strong.

QMCO's quarterly loss narrowed as revenue jumped 27%, while debt repayment and backlog momentum point to improving profitability ahead.

SoFi is back at a key price level, and a major macro shift may have just made the bull case stronger than ever.

Even if OpenAI delays its IPO, AMD stock should be fine.

Hut 8 has a multigigawatt pipeline of data center projects in the works, and lucrative hyperscaler deals that have fueled a meaningful rally.

Micron sees growth ahead for smartphones and PCs.

John Bolton is one of several foes of President Donald Trump who has been indicted since Trump regained the White House.

Ryanair has declined over the past six months as rising costs, macro uncertainty and weaker earnings estimates raise fresh questions about its near-term outlook.

Aerie powers AEO's growth with strong sales, disciplined execution and continued customer engagement momentum.

The gap between price and value on these names is getting harder to ignore by the day.

What happens when a thinly traded crypto with concentrated ownership hits a rough patch? MemeCore investors found out the hard way this week.

XRP has delivered 900%+ returns before, so many investors are betting it can do it again. Can it?

PYPL's TPV climbs 11% to $464B in Q1 2026 as Venmo, PSP momentum, debit cards and branded experiences help drive broad-based payment growth.

VEEV's Veeva EHS expands Quality Cloud with automated risk, compliance and safety workflows, aiming to replace legacy systems with a unified platform.

PBI's cash flow rebound is gaining investor attention as stronger margins, cost control and capital returns test its turnaround durability.

Bristol Myers Squibb leans on specialty medicines and a discounted valuation, while Johnson & Johnson boasts industry-leading margins and cash flow.

FRD is benefiting from record sales volumes and Century Metals gains, but steel price volatility and supplier dependence remain challenges.

Dyne is advancing therapies for rare muscle diseases while Viking targets the booming weight-loss market. See how their financials and risk profiles compare.

The memory shortage has become a windfall for storage makers.